GLUCOVANCE 500 mg/5 mg, film-coated tablet 30 tablets
Active ingredients: Metformin hydrochloride, Glyburide, Metformin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLUCOVANCE 500 mg/5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- MERCK SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Nov 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65940127CIP73580280CIP133400935802804Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GLIBENCLAMIDEcomprimé | 5 mg · un comprimé | SA |
| METFORMINEcomprimé | 390 mg · un comprimé | FT |
| CHLORHYDRATE DE METFORMINEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.